Enhanced medical fee waivers benefit over 49,000 patients, expanding support for low-income families and critical cases

Public healthcare fees and charges reform strengthens protection for poor, acute, serious and critical patients number of waiver recipients is 3.5 times annual total of previous year

The following is issued on behalf of the Hospital Authority:

The Hospital Authority (HA) spokesperson announced today (January 9) that in addition to the 600 000 people who have been benefiting from medical fee waivers both before and after the reform (including Comprehensive Social Security Assistance recipients, Old Age Living Allowance recipients aged 75 or above, and holders of Residential Care Service Voucher Scheme Level 0 vouchers), as of January 7, the HA has approved 49 310 medical fee waiver applications. This figure is 3.5 times of approximately 14 000 patients who received medical fee waivers in previous year, demonstrating that the enhanced medical fee reduction mechanism has significantly strengthened support for low-income families and underprivileged groups. Over the past week, many patients have benefited from the enhanced medical fee waivers mechanism, receiving immediate fee reduction when using Accident and Emergency Departments (A&E), outpatient and inpatient services.

The Hospital Authority (HA), Photo source: reference image

Medical fee waivers take effect covering more than 10 000 poor patients

As an essential component of the public healthcare fees and charges reform, the HA expanded its medical fee waivers mechanism at the same time, which significantly increased the number of eligible individuals from approximately 300 000 to about 1.4 million - around 4.6 times the previous number of beneficiaries. This ensures that limited medical resources can be more precisely directed to help those most in need: the poor, acute, serious, and critical patients. As of January 7, among the 49 310 medical fee waiver applications approved by the HA, 32 249 cases have completed assessment and received formal waiver certificates valid for up to 18 months but claimed . For patients who claim to meet the medical fee waivers eligibility criteria but are unable to submit supporting documents for financial assessment, the HA has exercised flexible arrangements to approve 17 061 "conditional waivers", allowing patients to obtain immediate medical fee reductions when using public healthcare services. These patients must submit relevant documentation within three months.

After the fees and charges reform, many patients are benefited for the first time from the expanded medical fee waivers mechanism, changing from paying full fees to receiving free services. From January 1 to 7, excluding the number of Comprehensive Social Security Assistance recipients, Old Age Living Allowance recipients aged 75 or above, and holders of Residential Care Service Voucher Scheme Level 0 vouchers who can continue to use their medical fee waivers, there are over 11 200 patients benefitted from the enhanced medical fee waivers mechanism, including:

• About 500 poor patients at A&Es,who were triaged as urgent, semi-urgent and non-urgent, received medical fee waivers, triple of last year's figure;

• About 2 100 poor patients received medical fee waivers for inpatient services, 3.5 times of last year's figure; and

• About 8 600 poor patients received medical fee waivers for specialist outpatient services, six times of last year's figure.

The HA spokesperson stated, "The data concerned shows obviously that the enhanced medical fee waivers mechanism, which is newly introduced in line with the public healthcare fees and charges reform, can allocate resources more precisely to strengthen protection for poor, acute, serious and critical patients, ensuring that no patient is denied from medical care due to lack of means."

The current situation regarding patients' applications and usage of medical fee waivers aligns with the HA's projection. The HA will continue to strengthen its manpower to provide assistance to patients in need. To ensure the integrity of the medical fee assistance system and prevent abuse, the HA will conduct regular reviews of approved cases.

Number of non-urgent A&E patients reduced significantly while treatment efficiency for emergency patients improved

Regarding A&E services, from January 1 to 7, 32 147 patients attended the 18 A&Es under the HA, significantly decreased by about 11.9 per cent of the same period last year. Among the cases, 1 807 patients were classified as critical and emergency cases, and 14 077 patients were classified as urgent cases, showing a slight increase compared to the same period last year. The remaining 16 263 patients were classified as semi-urgent and non-urgent cases, showing a significant decrease of 17.8 per cent compared to the same period last year. Since the implementation of the public healthcare fees and charges reform, the operations of public hospital A&E services has initially met expected results, including:

• Significant decrease in average daily A&E attendances by about 11.9 per cent;

• In the past seven days, about 1 800 critical and emergency patients exempted from A&E fees under the new fees and charges reform. These patients were required to pay the fees before the reform;

• For patients classified as urgent cases, the percentage of those being treated within 30 minutes - meeting the service pledge target - increased from 82.7per cent last year to 88.8 per cent, with average waiting time reduced from 22 to 19 minutes; and

• Among the five triage categories, semi-urgent and non-urgent patients decreased from 54.2 per cent in the same period last year to 50.6 per cent.

The HA spokesperson said, "The service data of the past week shows that the fees and charges reform allowed A&Es to perform their emergency care function more effectively. A&Es can better concentrate resources, treat patients with urgent medical needs more effectively, and improve treatment efficiency for urgent cases."

The HA will continue to closely monitor the fees and charges reform as well as the overall operations of services of public hospitals, in order to ensure achieving the aim of protecting poor, acute, serious or critical patients.

Photo source: reference image

CFS to follow up certain batches of powdered infant and young children formula with possible presence of Cereulide produced by Bacillus cereus

The Centre for Food Safety (CFS) of the Food and Environmental Hygiene Department (FEHD) today (January 10) said that, it took initiative to meet with Nestlé Hong Kong again today, and confirmed the company's today announcement of an additional batch of powdered infant and young children formula suspected to have possibly used the raw material concerned. Nestlé Hong Kong has voluntarily stopped sales, removed from shelves the affected products and has initiated a precautionary recall. The CFS has collected samples of powdered infant and young children formula from the market for Bacillus cereus testing, the test results so far were satisfactory. The Environmental and Ecology Bureau is also closely monitoring the supply situation of other formula milk powder and maintaining communication with other major suppliers. It is noted that there is sufficient formula milk powder to meet the demand.

The spokesman said, the CFS has been actively following up on Nestlé company's voluntary and precautionary recalls of certain batches of its powdered infant and young children formula in certain areas in Europe due to possible presence of Cereulide produced by Bacillus cereus in the individual raw material. According to the latest information from Nestlé Hong Kong today, an additional batch of its powdered infant and young children formula imported into Hong Kong might have used the raw material concerned. The CFS had earlier enhanced surveillance in the market and collected a sample from the above batch for testing of Bacillus cereus. The test result of the sample was satisfactory. Nevertheless, as a precautionary measure, Nestlé Hong Kong has voluntarily stopped sales, removed from shelves the affected products and has initiated a precautionary recall.

Product details are as follows:

Product name (Net weight): NAN PRO 1 2 HMO (800g)

Batch number: 51670742F2

Best-before date: June 16, 2027

Place of Origin: Germany

"The CFS met Nestlé Hong Kong again today, urging them to properly handle the product recall issue and respond to public enquiries, in order to safeguard consumers' legitimate rights and interests. In addition, the CFS and Nestlé Hong Kong have jointly followed up, six suspected affected batches of infant and young children formula products that had not entered the market were marked and sealed. An additional 15 batches are currently en route to Hong Kong and will also be marked and sealed upon arrival. The CFS will continue to closely monitor the recall matters and remain fully committed to ensuring food safety, " the spokesman said.

Nestlé Hong Kong has initiated a recall of the affected batches of the products concerned. For enquiries about the recall, members of the public may contact the company through the following channels:

Consumer services hotline: 2599 8874 / 2797 6031/ 2179 8136 (Monday to Sunday, 9am to 9pm)

Email: consumerservices@hk.nestle.com

WhatsApp: 5283 4139 (NESTLÉ® NAN®) / 2599 8871 (Wyeth® Nutrition)

Online form: forms.office.com/e/BhqMhWfsUG?origin=lprLink

Consumers may choose to bring along the products (brand new or opened) for refund at place of purchase, or at exclusive service counters of Nestlé Nutrition Services from January 13 (Tuesday) onwards, to settle the recall and refund of the batches of the products concerned. Details of the exclusive service counters are as follows:

Kowloon Services Counter

Address: G/F, Park Hovan Commercial Building, 18 Hillwood Road, Tsim Sha Tsui, Kowloon (MTR Jordon Station Exit D)

Contact number: 3996 8196

Office hour: Monday to Saturday, 11am to 7.30pm; Sunday, 1pm to 5.30pm (except public holidays)

Hong Kong Services Counter

Address: 1/F, Ka Nin Wah Commercial Building, 423-425 Hennessy Road, Hong Kong (MTR Causeway Bay Station Exit B)

Contact number: 3996 8197

Office hour: Monday to Saturday, 11am to 7.30pm (except Sundays and public holidays)

The CFS, through its Food Incident Surveillance System, noted earlier that certain batches of Nestlé powdered infant formula were being voluntarily recalled in Europe due to possible contamination with Bacillus cereus. Upon learning of the incident, the CFS has immediately initiated follow up actions, published food incident posts to inform the public and the trade about the issue, and has been actively following up on the incident and enhanced surveillance.

Over the past three days (as of 4pm on January 9), the FEHD received a total of 18 food complaints and enquiries suspected to be related to the infant and young children formula products, including one anonymous complaint without contact information. The CFS and the Environmental Hygiene Branch have promptly followed up on all cases, including contacting the parties concerned to obtain details and collecting samples for testing. In addition, the CFS has referred the cases to the health department for follow-up. At present, no food poisoning cases related to the formula have been recorded.

Bacillus cereus is commonly found in the environment. Unhygienic conditions in food processing and storage may give rise to its growth. Cereulide is a heat-stable toxin produced in food by some strains of Bacillus cereus. Consuming food contaminated with excessive Bacillus cereus or its heat-stable toxins may cause gastrointestinal upset such as vomiting and diarrhoea.

The spokesman urged members of the public not to let infants and young children consume the affected batches of the products, and to seek medical treatment for infants or young children who felt unwell after taking the products concerned. The trade should also stop using or selling the affected batches of the products immediately.

"The CFS continues to closely monitor the developments of the situation, follow up and take appropriate action," the spokesman said.

Source: AI-found images